DUBLIN--(BUSINESS WIRE)--The "Animal Health Active Pharmaceutical Ingredients Market Report - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The animal health active pharmaceutical ingredients market size is estimated to be USD 6.73 billion in 2021 and is expected to witness a CAGR of 7.21% during the forecast period 2022-2029.
The creation of new products, increased pet adoption rates and rising animal welfare awareness among people are projected to drive the market growth in near future. However, strict regulation is expected to restrain the market growth.
Segmentation: Animal Health Active Pharmaceutical Ingredients Market Report 2021-2029
By Application (Revenue, USD Million)
- Pet Hospital
- Pharmacy
- Other
Product (Revenue, USD Million)
- OnSAIDs & Anesthetics
- Anti-infectives
- Antiparasitics
- Others
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Companies Mentioned
- Biogrund GmbH (Germany)
- Ideal Cures Pvt. Ltd (India)
- Evonik Industries AG (Germany)
- Merck KGaA (Germany)
- Wacker Chemie AG (Germany)
- Colorcon (US)
- Roquette Freres (France)
- Finar Limited (India)
- Archer Daniels Midland Company (US)
- BASF SE (Germany)
- Lubrizol Corporation (US)
- Innophos Holdings (US)
- Kerry Group plc (Ireland)
- Air Liquide (France)
- Dow Chemicals (US)
- DMV-Fonterra Excipients (Germany)
- Associated British Foods plc (UK)
- JRS Pharma GmbH (Germany)
- Meggle GmbH & Co Kg (Germany)
- Fuji Chemical Industries Co. Ltd (Japan)
- Captisol (US)
- Corel Pharma Chem (India)
- Nitika Pharmaceutical Specialties Pvt. Ltd (India)
For more information about this report visit https://www.researchandmarkets.com/r/w2bibh
